AbbVie (ABBV) Presents Preliminary Results From Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6/17/2013 11:21:17 AM
More...
|
Positive Survival Data for Bristol-Myers Squibb Company (BMY)/AbbVie (ABBV)'s Blood Cancer Drug
6/17/2013 6:59:30 AM
More...
|
AbbVie (ABBV): We Can Win Race Against Gilead Sciences, Inc. (GILD) for First New Hepatitis C Drugs
6/14/2013 7:58:14 AM
More...
|
AbbVie (ABBV) Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis
6/13/2013 9:41:17 AM
More...
|
AbbVie (ABBV) Jumps Into $11.4 Million Series B for Avaxia Biologics, Inc.
6/7/2013 7:15:47 AM
More...
|
AbbVie (ABBV) to Participate in 34th Annual Goldman, Sachs & Co. Global Healthcare Conference
6/5/2013 6:46:59 AM
More...
|
AbbVie (ABBV) Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
6/3/2013 10:52:25 AM
More...
|
AbbVie (ABBV) Announces Market Availability of New CREON® (Pancrelipase) 36,000 Lipase-unit Capsules for Patients With Exocrine Pancreatic Insufficiency
5/30/2013 10:26:01 AM
More...
|
The AbbVie (ABBV) Culture Change Continues: 100 Scientists Will be Laid Off
5/30/2013 8:12:14 AM
More...
|
AbbVie (ABBV) to Participate in 2013 Jefferies and Co. Global Healthcare Conference
5/28/2013 7:14:41 AM
More...
|
|